Meta-analysis of Carvediol and Metoprolo in treatment of dilated car-diomyopathy with heart failure

Yao ZHANG,Qizhu TANG,Ning ZHANG,Mengqiao ZHOU

2015-01-01

Abstract:Objective To review the efficacies of Carvediol and Metoprolo in treatment of dilated cardiomyopathy with heart failure. Methods The randomized controlled trials about the efficacies of Carvediol and Metoprolo in treatment of dilated cardiomyopathy with heart failure were retrieved from the databases of Chinese biomedical database, CNKI, Wanfang, VIP, PubMed, Cochrane library, EMbase. The references of enrolled literatures were screened, and the quality of references was evaluated strictly and the data was extracted, and then the studies met with the quality specification were taken a Meta-analysis by RevMan 5.1 software. Results Totally 6 references were included, 438 patients in total. The results showed that, compared with Metoprolo, the clinical effective rate (OR=0.27, 95%CI:0.15-0.48, P<0.000 01), left ventricular ejection fraction (MD=-3.10, 95%CI:-4.75 to-1.44, P=0.0002), left ventricular end-diastolic inner diameter (MD=2.3, 95%CI:0.89-3.71, P=0.001) in Carvediol group had good effects, the differences were statistical-ly significant. Conclusion Carvediol can significantly improve left ventricular ejection fraction and left ventricular end-diastolic inner diameter of dilated cardiomyopathy with heart failure, improve the clinical effective rate, which deserves promotion.